scholarly journals Dasiglucagon, a next‐generation ready‐to‐use glucagon analog, for treatment of severe hypoglycemia in children and adolescents with type 1 diabetes: results of a phase 3, randomized controlled trial

2021 ◽  
Author(s):  
Tadej Battelino ◽  
Ramin Tehranchi ◽  
Timothy Bailey ◽  
Klemen Dovc ◽  
Anita Melgaard ◽  
...  
Sign in / Sign up

Export Citation Format

Share Document